Consolidated cash flow statements
(unaudited)
|
Three months ended 31 March |
|
(thousands of €) |
2019 |
2018 |
Net loss of the period |
(48,656) |
(37,283) |
|
|
|
Adjustment for non-cash transactions |
5,524 |
11,057 |
Adjustment for items to disclose separately under operating cash flow |
(1,517) |
(530) |
Adjustment for items to disclose under investing and financing cash flows |
(3) |
– |
Change in working capital other than deferred income |
(2,294) |
20,482 |
Decrease in deferred income |
(25,979) |
(34,458) |
|
|
|
Cash used in operations |
(72,925) |
(40,732) |
|
|
|
Interest paid |
(327) |
(500) |
Interest received |
1,565 |
1,428 |
Corporate taxes paid |
(11) |
– |
|
|
|
Net cash flows used in operating activities |
(71,698) |
(39,804) |
|
|
|
Purchase of property, plant and equipment |
(2,103) |
(1,192) |
Purchase of intangible fixed assets |
(1,201) |
(340) |
Proceeds from disposal of property, plant and equipment |
1 |
1 |
Acquisition of financial assets held at fair value through profit or loss |
(177) |
– |
Proceeds from sale of financial assets held at fair value through profit or loss |
82 |
– |
|
|
|
Net cash flows used in investing activities |
(3,398) |
(1,531) |
Payment of lease liabilities |
(1,248) |
(19) |
Proceeds from capital and share premium increases from exercise of warrants |
3,481 |
3,924 |
|
|
|
Net cash flows generated in financing activities |
2,233 |
3,905 |
|
|
|
Decrease in cash and cash equivalents |
(72,863) |
(37,430) |
|
|
|
|
|
|
Cash and cash equivalents at beginning of the period |
1,290,796 |
1,151,211 |
|
|
|
Decrease in cash and cash equivalents |
(72,863) |
(37,430) |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
4,968 |
(5,595) |
|
|
|
Cash and cash equivalents at end of the period |
1,222,901 |
1,108,186 |
The accompanying notes form an integral part of these condensed consolidated financial statements.